Unique ID issued by UMIN | UMIN000047563 |
---|---|
Receipt number | R000054240 |
Scientific Title | Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males. A randomized, double-blind, placebo-controlled, crossover study. |
Date of disclosure of the study information | 2022/04/28 |
Last modified on | 2022/10/21 09:10:13 |
Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males.
A randomized, double-blind, placebo-controlled, crossover study.
Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males.
A randomized, double-blind, placebo-controlled, crossover study.
Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males.
A randomized, double-blind, placebo-controlled, crossover study.
Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males.
A randomized, double-blind, placebo-controlled, crossover study.
Japan |
Healty subjects
Adult |
Others
NO
To explore continued effects on oxygen utilization during exercise in healthy adult males after a single intake of placebo or test food.
Efficacy
Oxygen uptake
Ventilatory equivalent for oxygen, Ventilatory equivalent, Carbon dioxide output, Ventilatory equivalent for carbon dioxide, Respiratory exchange ratio, Respiratory rate
Heart rate, Heart rate variability
Subjective exercise intensity (RPE)
Blood lactate concentration
Urinary excretion
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Single intake of test food
Single intake of placebo food
20 | years-old | <= |
50 | years-old | > |
Male
1) Healthy adult males
2) Persons who are able to intake foods, beverage, placebo/test foods, collect urine and stay at rest according to the predetermined schedule
1) Persons whose clinical laboratory test values are judged to be ineligible for the study by the investigator.
2) Persons with or have a history of disorders of the digestive, circulatory, endocrine system, and are judged to be eligible for the study by the investigator.
3) Persons who habitually use drugs for the purpose of treating diseases, in principal.
4) Persons who use healthy food or supplement which are able to affect this study.
5) Persons with food allergies.
6) Persons who are judged to be ineligible for the study for any other reason by the investigator.
16
1st name | Tsubasa |
Middle name | |
Last name | Mizokami |
Otsuka Pharmaceutical Co., Ltd.
Saga Nutraceuticals Research Institute
842-0195
5006-5 Yoshinogari-cho Kanzaki-gun, Saga,
0952-52-1522
Mizokami.Tsubasa@otsuka.jp
1st name | Tsubasa |
Middle name | |
Last name | Mizokami |
Otsuka Pharmaceutical Co., Ltd.
Saga Nutraceuticals Research Institute
842-0195
5006-5 Yoshinogari-cho Kanzaki-gun, Saga,
0952-52-1522
Mizokami.Tsubasa@otsuka.jp
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Profit organization
Otsuka Pharmaceutical Co., Ltd.
Shinagawa Grand Central Tower, 2-16-4, Konan, Minato-ku, Tokyo
03-6717-1499
shimizu_se@otsuka.jp
NO
2022 | Year | 04 | Month | 28 | Day |
Unpublished
15
Completed
2022 | Year | 04 | Month | 28 | Day |
2022 | Year | 04 | Month | 21 | Day |
2022 | Year | 06 | Month | 09 | Day |
2022 | Year | 09 | Month | 24 | Day |
2022 | Year | 09 | Month | 26 | Day |
2022 | Year | 09 | Month | 27 | Day |
2022 | Year | 10 | Month | 10 | Day |
2022 | Year | 04 | Month | 22 | Day |
2022 | Year | 10 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054240